AssayIndex

WWB-2604-E3153

Ipamorelin · 5 mg declared · Wuhan Wansheng Biotechnology Co., Ltd. · manufactured 20 Apr 2026

CHARACTERISED
Lot code
WWB-2604-E3153
Supplier
WWB — Wuhan Wansheng Biotechnology Co., Ltd.
Compound
Ipamorelin
Compound class
Growth-hormone axis peptides
Declared label claim
5mg
Manufacture date
20 Apr 2026
Index quarter
2026-Q2
Independent assays
10
Laboratories involved
Janoshik, Medutest, VendorInvestigate
Provenance mix
Buyer-sourced ×2 · Supplier-supplied ×7 · Laboratory-retained ×1
Section 1

Reproducibility across independent tests

Every report below is an observation of the same physical material. What they disagree about is measurement; what they agree about is the lot. The size of the disagreement is compared against what the contributing laboratories' own repeatability figures predict.

Independent assays 10
Median purity 99.93% n=10
Spread (max − min) 0.21pp n=10
Standard deviation 0.066pp n=10
97.197.698.198.699.199.6100.1This lot (WWB-2604-E3153)This lot (WWB-2604-E3153): Q1 99.93, median 99.93, Q3 99.93, n=10outlier 99.72outlier 99.89n=10All IpamorelinAll Ipamorelin: Q1 98.97, median 99.48, Q3 99.93, n=223outlier 97.34outlier 97.51n=223 Purity (% area)
Figure 1. This lot's independent purity results against the whole Ipamorelin record set in the index. The vertical line is the index acceptance specification for the growth-hormone axis peptides class, 99.0 % area. A narrow box on the top row against a wide box on the bottom row is the ideal reading: it means the disagreement between lots is much larger than the disagreement within this one.
Section 2

Member reports 10

Every report the index holds on this lot. Each is a page carrying its own chromatogram, mass spectrum, mass balance, provenance and caveats.

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-041303WWB-2604-E3153Janoshik2026-Q299.935.92Supplier-supplied0PASS
AX-2026-041304WWB-2604-E3153Medutest2026-Q299.936.34100.6Supplier-supplied1FAIL
AX-2026-041305WWB-2604-E3153VendorInvestigate2026-Q299.935.90Buyer-sourced0PASS
AX-2026-041306WWB-2604-E3153Janoshik2026-Q299.935.18Supplier-supplied0PASS
AX-2026-041307WWB-2604-E3153Medutest2026-Q299.725.9397.0Supplier-supplied1MARGINAL
AX-2026-041308WWB-2604-E3153VendorInvestigate2026-Q299.936.24103.9Buyer-sourced0PASS
AX-2026-041309WWB-2604-E3153Janoshik2026-Q299.936.14Supplier-supplied0PASS
AX-2026-041310WWB-2604-E3153Janoshik2026-Q299.935.33100.5Supplier-supplied0PASS
AX-2026-041311WWB-2604-E3153Janoshik2026-Q299.935.52Supplier-supplied0PASS
AX-2026-041312WWB-2604-E3153Medutest2026-Q299.896.39104.4Laboratory-retained1MARGINAL
Section 3

By laboratory

Where more than one laboratory assayed this lot, the difference between them is a paired observation of their relative bias — the same material, the same time window, different instruments. Those pairs are what the index's bias estimates are built from.

LaboratoryReportsPurity results (% area)MedianGradientPublished bias (pp)Bias-adjusted
Janoshik599.93, 99.93, 99.93, 99.93, 99.9399.9330min+0.0099.93
Medutest399.93, 99.72, 99.8999.8925min+0.0899.81
VendorInvestigate299.93, 99.9399.9332min-0.11100.04

This lot contributes 3 paired comparisons to the inter-lab analysis.

Section 4

The supplier's certificate for this lot

One number the supplier wrote, beside the median of the numbers other people measured on the same physical material. That comparison is only available because the index groups by lot.

FigureSupplier COAThis reportIndex note
Purity (% area)99.9099.93divergence -0.03 pp vs batch median
Total impurities (% area)not stated0.07
Largest single impurity (% area)not stated0.05
Water (%)5.05.92
Counter-ion (%)7.97.30
Peptide content (%w/w)86.5not determined
Endotoxin (EU/mg)0.40not determined
Method stated on certificateYEScolumn, gradient and wavelength given
Section 5

Impurity fingerprint

The named impurities reported across this lot's assays, with how consistently each was seen. A fingerprint is what allows two lot numbers held by different companies to be identified as one bulk.

Named impurityReported inMedian % areaRange
des-Lys (−128 Da)10 / 100.030.02–0.10
Aib-deletion sequence (−85 Da)6 / 100.030.03–0.07
oxidised Trp (+16 Da)5 / 100.050.05–0.10
[D-Trp]-epimer2 / 100.030.02–0.04
Section 7

What this rollup does not establish